Franco-Swiss pharmaceuticals company Sanofi-Aventis has finally got the nod from the US drugs regulator for its new Framingham manufacturing facility, which forms part of its Genzyme acquisition.
IC TIP:
Sell
at
54€
The plant should start to relieve the production problems that have dogged Genzyme since before Sanofi acquired it.